Postnatal diagnosis of congenital toxoplasmosis is imperative to ensure optimal medical care.

The early identification of the specific antibodies developed by the newborn is therefore of crucial importance, but is made difficult by their joint presence with maternal immunoglobulins G (IgG) in the serum of the newborn.

The IgName project aims to identify newborn IgGs specific for Toxoplasma gondii, by exploring the individual signatures carried by the heavy chain of IgG and resulting from polymorphisms of several amino acids.

Affinity purification methods are developed and applied to plasmas from the TOXODIAG and PlasDCty studies.

A device adapted to miniaturize these protocols, as well as mass spectrometry for the proteogenomic characterization of IgG, and a mapping of the glycosylation of IgG are also implemented. (https://anr.fr/Projet-ANR-19-CE44-0004)

Northern Partnership

ESPCI -> SMBP
(Biological Mass Spectrometry and Proteomics)

Southern Partnership

Calendar

2020-2023

Direction

FLORENCEMN

Florence MIGOT-NABIAS

GENE manager Deputy Director of the UMR, Director of Research
Paris, Faculty of Pharmacy

UMR Merit teams

CELIA

Célia DECHAVANNE

GENE manager Responsible for setting up in Benin, Research Officer
Benin
avatar

Magalie DAMBRUN

GENE manager Regulatory unit managers, Assistant engineer
Paris, Faculty of Pharmacy
avatar

Mariama SOUFFOU

GENE manager PhD student
Paris, Faculty of Pharmacy